Kit for assessing the risk of complications in patients with systemic inflammatory response syndrome (SIRS)

A kit for the in vitro measurement of a quantity of at least one transcript of the IL7R gene in a biological blood sample, comprising:

• specific reagents for measuring the quantity of said at least one transcript of the IL7R gene in said biological blood sample, said at least one transcript comprising the transcript IL7R-001 of SEQ ID NO:
• 2, or a variant of the transcript IL7R-001 of SEQ ID NO:
• 2 having at least 99% identity with said sequence, including the following amplification primer pair:
• forward primer with SEQ ID NO:
• 12 and reverse primer with SEQ ID NO:
• 13 and a probe with SEQ ID NO:
• 14, said probe being either tagged with a marker, or immobilized on a solid support;
• and
• a blood control sample that is a blood sample that is calibrated and contains the quantity of said at least one transcript of the IL7R gene that corresponds to the mean quantity measured in a pool of reference blood samples from human patients who are in a state of septic shock when the reference blood samples are taken, or who were in a state of septic shock within 72 hours after the reference blood samples were taken, and who were known to have survived, and/or a blood control sample that is a blood sample that is calibrated and contains the quantity of said at least one transcript of the IL7R gene that corresponds to the mean quantity measured in a pool of reference blood samples from human patients who are in a state of septic shock when the reference blood samples are taken, or who were in a state of septic shock within 72 hours after the reference blood samples were taken, and who were known not to have survived.